Meta-analysis is becoming an increasingly popular and powerful tool to integrate findings across studies and OMIC dimensions. But there is the danger that hidden dependencies between putatively "independent" studies can cause inflation of type I error, due to reinforcement of the evidence from false-positive findings. We present here a simple method for conducting meta-analyses that automatically estimates the degree of any such nonindependence between OMIC scans and corrects the inference for it, retaining the proper type I error structure. The method does not require the original data from the source studies, but operates only on summary analysis results from these in OMIC scans. The method is applicable in a wide variety of situations including combining GWAS and or sequencing scan results across studies with dependencies due to overlapping subjects, as well as to scans of correlated traits, in a meta-analysis scan for pleiotropic genetic effects. The method correctly detects which scans are actually independent in which case it yields the traditional metaanalysis, so it may safely be used in all cases, when there is even a suspicion of correlation amongst scans.
Introduction
Meta-analysis is becoming a common tool for integrating findings across multiple OMIC scans (e.g. Hsu et al., 2010; Moutselos et al., 2010) . The advantages are most obvious when investigators do not have access to all of the source data, but only to summary results from each study. But such a meta analysis strategy is sometimes analytically preferred even when all of the individual level data are available, in situations where there is enough potential for study heterogeneity that a combined supermodel, mega-analysis would require estimation of many cross-study-by-covariate interaction terms (e.g. Ioannidis et al., 2002 ).
However, one potential problem with such meta-analyses is the danger of hidden nonindependencies between elements of the scans that can occur when data are generated with overlapping subjects, related subjects, or other information. For example, there are overlapping subjects in several large scale NIH sponsored genetic epidemiology studies, such as the Framingham Heart Study, the NHLBI Family Heart, the HyperGen study, ARIC study, etc. Even if subjects are distinct across studies, if there are closely related subjects (e.g. siblings) across studies, this can cause non-independence of the observations and potentially inflate type I error in meta-analyses. The reason is that such non-independence violates the basic i.i.d. (independent and identically distributed) random variables assumptions of most statistical tests and models, including traditional meta-analysis ones, so that if a type I error (false positive) occurs in one study, and there is overlapping information to another study, then the other study is more likely to reflect this same false-positive trend in its corresponding result. A meta-analysis which ignores this fact, will take the reinforcement of "signals" between the two studies as a sign of independent replication, and overstate the significance of the meta-findings.
Conneely and Boehnke (2010) provide a method of conducting meta-analysis of correlated SNPs within an LD region, on multiple correlated traits, but they assume that the multiple studies that are being meta-analyzed are strongly independent, and they do not consider the possibility of overlapping subjects or correlated information between the OMIC scans. Riley et al. (2007) discuss the properties a bivariate random effects meta analysis model, in which they estimate what they call "between study correlation," but it is clear from their hierarchical model that they are in fact making the assumption that studies are strongly independent of one another. Their "between study correlation" is actually the correlation between the true parameter values within a study, as distinct from what they call the "within study correlation" which is the correlation between the pair of estimates of the parameters for each study. So they are not modeling the kinds of across scans correlations that would arise from overlapping subjects or any of the other reasons that we consider in our correlated meta-analysis model. Lin and Sullivan (2009) provide an efficient method for analyzing overlapping subjects in multiple GWAS to avoid inflation of type I error, but their approach is only applicable to case/control data, not quantitative traits, and it requires either having access to all individual level data or at least having a complete census accounting of the exact numbers of overlapping cases and controls. Sometimes such information is not easily shared amongst studies, due to IRB concerns, and sometimes, such overlaps may not even be known to the investigators, as subjects may not always volunteer that they are participating in multiple studies. Turchin and Hirschhorn (2012) have provided a clever way to forensically detect overlapping subjects using cryptographic hashes on GWAS data that preserves confidentiality of subjects. But as stated above, overlapping subjects is not the only cause for non-independence. Hartung (1999) proposed the first true correlated meta-analysis test, using an approach similar to ours based upon the inverse normal MVN. But his approach estimates a single dependency correlation amongst all scans, assuming they are all equally correlated, which can be problematic when some pairs of OMIC scans are more related than others. Additionally, his method estimates this single correlation for each hypothesis (or "OMIC unit", below) separately. This works well under the null hypothesis OMIC units, avoiding accumulation of evidence from correlated false-positives which results in inflation of type I error. But this approach can overcorrect for those OMIC unit tests under either the complete alternative hypothesis or partial alternative (incomplete null), resulting in potential loss of power. There, we want correlated true positive evidence to accumulate-we do not want to correct it out. Our approach, first proposed by Province in 2005 for combining linkage scans, estimates the complete MxM correlation matrix for M OMIC scans, and thus allows for different scans to be correlated at different levels. We also estimate the average study dependency correlation matrix across all OMIC units in a set of scans, exploiting the biological fact that most of the OMIC units will be under the null. Thus, our method is more likely to only be correcting for dependencies under the null, retaining power under the alternative (or partial alternative) OMIC units.
Methods

OMIC unit of inference
Definition: An "OMIC unit of inference" is the basic unit for which statistical testing is performed for a particular OMIC scan.
For example, in a micro-array experiment, the OMIC unit of inference would be the gene, since the scan would consist of one statistical test for each of the 20,000 genes on the array. In a proteomic scan, the OMIC unit would be "proteins", since we have one statistical test for each measured protein.
In a linkage scan, the OMIC unit of inference might be the linkage markers themselves, or it might be centimorgan locations equally spaced throughout the genome, at which Identity-By-Descent (IBD) estimates have been made for each relative pair. There, we would have one multipoint LOD-score for each cM location. In a Whole Exome Sequencing (WES) experiment where the goal is to find rare variants, the OMIC unit of inference could be the variants themselves if power is sufficient to support individual testing of rare variants. But often there is not enough power to detect rare variants at an individual variant level (unless the variants are unusually penetrant). More commonly a statistical burden test is applied, so that the OMIC unit inference would be the gene, not the variant. Even though the smallest unit of measurement in the WES is the variant, the statistical tests are conducted at the gene level not the variant level, by collapsing/weighting all exonic variants within the same gene into a single composite predictor for that gene. So the gene is considered the OMIC unit of inference in this case. In a GWAS, the most natural OMIC unit of inference would be SNPs genotyped on the GWAS chip. But this might be reduced to a gene-level OMIC unit of inference, by taking, say, only the most significant SNP for each gene. Or it might be expanded to include all SNPs catalogued in a standard reference panel, such as HapMap or 1000 Genomes, by first performing genetic imputation (estimating the unmeasured SNPs via haplotype matching) and then conducting statistical tests on each imputed as well as measured SNP.
Harmonization of OMIC units of inference and missing data patterns
In order to conduct any meta-analyses of multiple OMIC scans we must first put them all on a common OMIC unit of inference scale, so that we can see if the combined evidence reinforces or destroys the overall signal at that particular OMIC unit. Exactly how this is done depends very much on the scientific goals, the types of OMIC scans one wishes to meta-analyze, the granularity and extent of the available data, and many other factors which we will not address in this paper. It is important to note that the methods we propose here do not depend upon the details of the process by which harmonization of OMIC units of inference across scans is accomplished. Nor is it necessary that this is accomplished comprehensively with identical OMIC units of inference across all OMIC scans. We can in fact have quite complex patterns of missing data within and across the OMIC scans, and our method will still apply. We do not make the strong assumption that data are missing "at random", but instead, we make the slightly weaker assumption that the missing data patterns are "ignorable." For example, we may wish to meta-analyze "I" different expression array experiments along with "K" different GWAS scans in combination with "J" linkage scans, and "M" WESs. We can reduce each of these I+J+K+M scans at the gene OMIC unit of inference, by taking the "most significant" SNP/gene in the GWASes, the highest LOD score over each gene in the linkage scans, and use burden tests for each gene in the exome scans. But we may also be interested in going beyond the genes into the intergenic regions, leaving out the expression arrays, and meta-analyzing the J+K+M GWAS+linkage+exome scans. We might define intergenic OMIC units as contiguous regions of open chromatin defined in functional experiments, contiguous regions of high species conservation. Or we might include some of the genes from the "I" expression arrays for those regions that are "known" to play regulatory role for the genes (e.g. eQTL regions for the gene).
Correlated Meta-Analysis of p-values
Suppose we have conducted N different OMIC scans on M common OMIC units of inference. Let PNxM=(pij) for i=1,…,N and j=1,…,M be the NxM matrix of p-values for the N scans of across the M OMICs units For each i, j let Z = Φ-1(1-P) denote the element-wise monotonic "complement probit" transformation of p-values to z-scores, where Φ(z) denotes the cumulative distribution function of the unit normal, N(0,1), i.e. Φ(z) = √ For each row "j," corresponding to a particular OMIC unit of inference, we look at the Nx1submatrix formed by taking only the j th -row of PNxM , and denote this vector by P (j) Nx1. It is this set of p-values that we wish to meta-analyze to test the combined effect of the jth OMIC unit across all N scans.
We apply a theorem from multivariate normal (MVN) distribution theory, whose proof is found in Anderson (2003):
,Σkxk], and D1xk is any vector of constants, then the linear combination D1xk Zkx1 ~ N[D1xk μ kx1 , D1xk Σkxk D'kx1]. In particular, when k=N, D1xN = 11xN (i.e. the 1xN vector of all "1"s) and μ Nx1 = 0 Nx1 (i.e. the Nx1 vector of all "0"s), then out meta-analysis Z-value is given by
We then convert back from the z-score scale back to the p-value scale using the monotonic inverse transformation to the one above, to get the meta-analysis p-value: Pmeta = 1 -Φ(Zmeta) . Note that if the j th OMIC unit does not have a significance test result for one or more of the N scans, then the corresponding entries in P (j) Nx1 will be missing (this will happen if data are low quality for that OMIC unit in one or more scans or if OMIC unit harmonization is not complete across scans for whatever reason). In such cases, we may use the basic property of the MVN distribution that every subdimensional space is also MVN distributed. Specifically, if Nj < N is the number of non-missing pvalues for the j th OMIC unit, and we denote by P (j)* Njx1 the Njx1 submatrix of P (j) Nx1 with all missing pvalue rows deleted, then Theorem (1) still applies to k=Nj, the corresponding sub-dimensional components of D (j)* 1xNj, μ (j)* Njx1 and Σ (j)* NjxNj being the non-missing submatricies of D1xN, μNx1 and ΣNxN , respectively.
We illustrate the application of this theorem to the meta-analysis of OMIC scans with two extreme mathematical examples. 
is the same result we get from applying Theorem 1.
( ) ( )
These two examples represent the extreme cases and make sense. In Example 1, when all scans are really independent, the Σkxk matrix is the identity, and our correlated meta-analysis method is the same as the traditional meta-method. In the other extreme, in Example 2, when all scans are completely correlated, the Σkxk matrix becomes the 1kxk matrix, and there is really just one scan, so the meta-analysis should recognize this and just return the original scan, which our correlated metamethod does, with no inflation of type I error.
Estimating Σkxk from the tetrachoric correlations amongst the OMIC scans themselves
Unlike the two simple examples above, in practice with real data, we will not know the values of the Σkxk matrix. However, if entire OMIC scans are available to us, we can exploit this fact to estimate Σkxk , by making using of the following assumption:
Assumption 1:
In any OMIC scan, by far (in fact, by several orders of magnitude) most of the statistical tests will be under the NULL hypothesis --.e. the OMIC units of inference are actually statistically independent of the phenotype being scanned.
With this assumption, we can use the observed correlations between OMIC scans to obtain our estimate of Σkxk., and then apply Theorem 1 to conduct our correlated meta-analysis.
Note that this is a biologically motivated assumption, which stems from our understanding of the OMIC architecture of phenotypes and traits, i.e. that for any fixed trait, most of the genome, exome, proteome, etc. is neutral. There may be (hopefully is) some "contamination" of the alternative hypotheses somewhere within the OMIC scan (otherwise, our scans are fruitless). But OMIC analysis experience tells us (as does population genetic theory), that the number of true OMIC signals should be far outnumbered by the number of noise OMIC units of inference. Nonetheless, if we simply estimate Σkxk across scans between corresponding OMIC units there are two problems. The first is that the p-value scale is uniformly distributed under the null hypothesis and we are assuming that we are dealing with a MVN distribution in Theorem 1. But this can be easily handled by making use of the complement probit transformation discussed above. The second, bigger problem is that the contamination of the OMIC units that are under the alternative should not so easily be dismissed as trivial. Yes, Assumption 1 tells us that they are small in frequency, but it says nothing about their impact on the estimate of Σkxk. Correlated, highly significant true signal results may be small in number but highly influential on the estimate of Σkxk. Worse, we do not want to overestimate Σkxk. because we are downweighting the results of our meta-analysis by its magnitude. Σkxk is supposed to be estimating the correlation between OMIC scans only for those OMIC units under the H0, because we want to avoid accumulating evidence across highly correlated scans that are only due to correlations of type I errors (due to overlapping subjects, relatedness, etc.). But we do NOT want to down weight evidence at OMIC units that are under the alternative hypothesis. In fact, we want the meta-p-values to be as significant as possible here. But we do not know which OMIC units are under the null and which are under the H1 (or we would not be doing the meta-analysis in the first place). We can minimize the impact of this contamination of the alternative hypothesis by using the tetrachoric correlation instead of the Pearson correlation in Σkxk. To do this, we first truncate all of the individual scan Z scores into two categories (Z < 0) vs (Z > 0). Then, at each common OMIC unit, if there are M scans, we form the M dimensional 2x2x…x2 table of scores across all scans, from which we estimate the tetachoric correlation matrix Σkxk. The tetrachoric correlation is less sensitive to contamination from the alternative hypothesis, because it lumps them with all moderately significant and even non-significant findings at the P<0.5 level. Thus, it provides some protection for over correction of the correlation amongst OMIC scans.
Results
Simulations
To validate the correlated meta-analysis method, we performed a series of simulation experiments. We generated 100 simulation replications of 3 OMIC scans on 10,000 OMIC units each, with a known correlational structure. For each replication, we conducted both the traditional meta-analysis (which assumes the 3 scans are independent) as well as our correlated meta-analysis procedure, which estimates the tetrachoric correlations between scans of the truncated p-values across the OMIC units of inference, and then uses that correlation matrix to correct the meta-analysis inference, as described above. The results of our simulations are shown in Table 1 , where we catalog the distribution of estimates across the 100 simulation experiments, and Figure 1 , where we show the Quantile-Quantile (Q-Q) plot for a typical (the first) replication's meta-analysis of the 3 scans. Figures 1a and 1b ( for the 3 independent scans), verify that there is no inflation of type I error in this case, but more importantly from the correlated meta-analysis view, there is no over conservatism. The p-values are just as true estimating the 3 correlations to be nearly zero as they are assuming them to be zero, so there is no harm in applying the correlated meta-analysis procedure even when the 3 scans really are independent. The correlated meta will tell us what it thinks are the correlations, and will correct for them, regardless of their magnitude.
For the 3 correlated OMIC scans (bottom half of Table 1 ), we generated the scans pairwise correlated at 0.5, 0.2 and 0.9, respectively, and then applied traditional as well as our correlated meta-analysis method. As can be seen, our correlated meta-method accruately estimated the 3 correlations using the tetrachoric approach, across all 100 replications. More importantly, our correlated meta-analysis method correctly produces Z-scores with the proper 0,1 first and second moments. Whereas the traditional meta-analysis, yields a meta-Z-score with a badly inflated variance (Standard Error is approximately 1.4). This results in the traditional meta being overly liberal, since it calculates Pvalues assuming it's meta-Z score has a variance of 1, instead of 1.4. The inflation is readily apparent in the Q-Q plot of Figure 1c , compared to 1d. Finally, we demonstrate the utility of our correlated meta-analysis procedure on a real data example, from a GWAS on the NHLBI Family Heart Study. In Table 2 , we show the results of combining two GWASes from the same study on two highly correlated traits to look for pleiotropy. Note that this is an extreme example of overlapping subjects (ALL 2,767 of them overlap), so the Lin and Sullivan method would not be of much help here, but if we do the traditional meta-analysis, we are in real danger of having type I errors accumulate in this situation. For traits Body Mass Index (BMI) and Waist Circumference (WC), the tetrachoric correlation between the scans of these two highly correlated variables is estimated to be 0.70. Ignoring this correlation with the traditional meta-analysis, results in meta-P~10 -10 for the SNPS listed which are far above the GW threshold for significance. However, the correlated meta-analysis method finds a more moderate level of evidence at P~10 -6 , suggesting that the traditional analysis is very much inflating the evidence. On the other hand, for HOMA (a measure of insulin resistance based upon insulin/glucose levels) and WC, the estimated tetrachoric correlation is 0.14. Here the traditional and correlated meta-analyses are in better agreement that indeed, there appears to be genome-wide significant pleiotropy at this locus for these two traits.
Example Pleiotropy Scanning in the NHLBI Family Heart Study
Discussion
Our correlated meta-analysis method provides a simple, robust approach to integrate information across multiple OMIC scans so as to avoid inflation of type I error due to hidden dependencies. Our method makes few statistical assumptions. It first estimates empirically the degree of non-independence between the OMIC scans, and then uses this estimate to corrects the meta-inference. The method does not require any additional knowledge of numbers of overlapping subjects, nor any preliminary forensic analyses, and provides the correct type I error when scans are correlated, regardless of the number and character of its source causes, as part of the meta-analysis itself. It is applicable for combining OMIC scans on quantitative, qualitative or any combinations of phenotypes. It can even be used to scan for evidence of pleiotropic effects when subjects are completely overlapping. When OMIC scans actually are independent, it estimates this correctly, and becomes the same as the traditional meta-analysis test. Thus, the method can be safely used in any situation, when there is any doubt that there may be violations of study independence assumptions.
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